|
CA1115212A
(en)
*
|
1978-02-10 |
1981-12-29 |
Emilio Kyburz |
Pyrrolidine derivatives
|
|
JPS5581865A
(en)
*
|
1978-10-30 |
1980-06-20 |
Fujisawa Pharmaceut Co Ltd |
5-fluorouracil derivatives and their preparation
|
|
US4349552A
(en)
*
|
1978-10-30 |
1982-09-14 |
Fujisawa Pharmaceutical Company, Ltd. |
5-Fluorouracil derivatives, and their pharmaceutical compositions
|
|
NZ221717A
(en)
|
1986-09-10 |
1990-08-28 |
Sandoz Ltd |
Azaindole and indolizine derivatives and pharmaceutical compositions
|
|
MX19185A
(es)
|
1989-01-20 |
1993-12-01 |
Pfizer |
Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.
|
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
FR2687402B1
(fr)
|
1992-02-14 |
1995-06-30 |
Lipha |
Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
|
|
DE4304455A1
(de)
|
1993-02-15 |
1994-08-18 |
Bayer Ag |
Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
IL129871A
(en)
|
1994-05-06 |
2003-11-23 |
Pharmacia & Upjohn Inc |
Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
|
|
JPH10510510A
(ja)
|
1994-06-09 |
1998-10-13 |
スミスクライン・ビーチャム・コーポレイション |
エンドセリン受容体拮抗物質
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
US5821243A
(en)
|
1996-07-22 |
1998-10-13 |
Viropharma Incorporated |
Compounds compositions and methods for treating influenza
|
|
GB9721437D0
(en)
|
1997-10-10 |
1997-12-10 |
Glaxo Group Ltd |
Heteroaromatic compounds and their use in medicine
|
|
AU2494300A
(en)
|
1999-01-07 |
2000-07-24 |
American Home Products Corporation |
3,4-dihydro-2h-benzo(1,4)oxazine derivatives
|
|
CA2355342A1
(en)
|
1999-01-07 |
2000-07-13 |
American Home Products Corporation |
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
|
|
US6313126B1
(en)
|
1999-01-07 |
2001-11-06 |
American Home Products Corp |
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
|
|
US6265403B1
(en)
|
1999-01-20 |
2001-07-24 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
AR028475A1
(es)
|
1999-04-22 |
2003-05-14 |
Wyeth Corp |
Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
|
|
US20030153560A1
(en)
|
1999-04-23 |
2003-08-14 |
Salituro Francesco G. |
Inhibitors of c-Jun N-terminal kinases (JNK)
|
|
WO2001001986A1
(en)
|
1999-07-02 |
2001-01-11 |
Lipton Stuart A |
Method of reducing neuronal injury or apoptosis
|
|
GB9919843D0
(en)
|
1999-08-20 |
1999-10-27 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE19948417A1
(de)
|
1999-10-07 |
2001-04-19 |
Morphochem Ag |
Imidazol-Derivate und ihre Verwendung als Arzneimittel
|
|
US20020065270A1
(en)
|
1999-12-28 |
2002-05-30 |
Moriarty Kevin Joseph |
N-heterocyclic inhibitors of TNF-alpha expression
|
|
EP1257546A1
(en)
|
2000-02-17 |
2002-11-20 |
Amgen Inc. |
Kinase inhibitors
|
|
US7041277B2
(en)
|
2000-03-10 |
2006-05-09 |
Cadbury Adams Usa Llc |
Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
|
|
CA2308994A1
(en)
|
2000-05-19 |
2001-11-19 |
Aegera Therapeutics Inc. |
Neuroprotective compounds
|
|
DK1309592T3
(da)
|
2000-08-14 |
2006-08-21 |
Ortho Mcneil Pharm Inc |
Substituerede pyrazoler
|
|
MXPA03001960A
(es)
|
2000-09-06 |
2004-03-18 |
Johnson & Johnson |
Un metodo para tratar alergias.
|
|
NZ524682A
(en)
|
2000-09-06 |
2004-11-26 |
Ortho Mcneil Pharm Inc |
A method for treating allergies using substituted pyrazoles
|
|
UY26942A1
(es)
|
2000-09-20 |
2002-04-26 |
Abbott Lab |
N-acilsulfonamidas promotoras de la apoptosis
|
|
MXPA03005432A
(es)
|
2000-12-22 |
2003-09-10 |
Wyeth Corp |
Compuestos de heterociclilindazol y -azaindazol como ligandos de 5-hidroxitriptamina-6.
|
|
DE60239097D1
(de)
|
2001-03-02 |
2011-03-17 |
Gpc Biotech Ag |
Drei-hybrid-assaysystem
|
|
SI1392697T1
(en)
|
2001-03-14 |
2005-02-28 |
Wyeth |
Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f)quinoline
|
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
|
EP1381600A1
(en)
|
2001-04-24 |
2004-01-21 |
Wyeth, A Corporation of the State of Delaware |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
|
|
US6656950B2
(en)
|
2001-04-25 |
2003-12-02 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
|
|
EP1381612A1
(en)
|
2001-04-26 |
2004-01-21 |
Wyeth |
Antidepressant aza-heterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
|
|
US6593350B2
(en)
|
2001-04-26 |
2003-07-15 |
Wyeth |
Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
|
|
ES2269678T3
(es)
|
2001-04-26 |
2007-04-01 |
Wyeth |
Derivados azaheterociclilmetilicos antidepresivos de 2,3-dihidro-1,4-dioxino (2,3f) quinolaxina.
|
|
CA2445543A1
(en)
|
2001-04-26 |
2002-11-07 |
Hong Gao |
Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-¬1,4|-benzodioxans
|
|
ES2247327T3
(es)
|
2001-04-26 |
2006-03-01 |
Wyeth |
Derivados azaheterociclimetilicos antidepresivos (isrs) de 7,8-dihidro-3h-6,9-dioxa-1,3-diazaciclopenta(a) naftaleno.
|
|
US6555560B2
(en)
|
2001-04-30 |
2003-04-29 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
|
|
JP2004528352A
(ja)
|
2001-04-30 |
2004-09-16 |
ワイス |
抗うつ作用を持つ７，８−ジヒドロ−１，６，９−トリオキサ−３−アザ−シクロペンタ［ａ］ナフタレンのアザヘテロ環メチル誘導体
|
|
GB0111186D0
(en)
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
|
CN1247590C
(zh)
|
2001-05-17 |
2006-03-29 |
惠氏公司 |
2,3－二氢－1,4－二氧芑并[2,3－f]喹啉衍生物的合成方法
|
|
US6825190B2
(en)
|
2001-06-15 |
2004-11-30 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
WO2003010169A1
(en)
|
2001-07-25 |
2003-02-06 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 7, 8-dihydro-6h-5-oxa-1-aza-phenanthrene
|
|
BR0211900A
(pt)
|
2001-08-14 |
2004-08-24 |
Toyama Chemical Co Ltd |
Método para inibição do desenvolvimento de vìrus e/ou virucida, análogos de nucleotìdeo de pirazina e de nucleosìdeo de pirazina, precursor do inibidor da polimerase de rna, inibidor da polimerase de rna, método para tratar pacientes infectados por vìrus, e, usos de um análogo de nucleotìdeo de pirazina ou um sal deste e de um análogo de nucleosìdeo de pirazina ou um sal deste
|
|
US20040236110A1
(en)
|
2001-09-26 |
2004-11-25 |
Ladouceur Gaetan H |
Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
|
|
WO2003031439A1
(en)
|
2001-10-05 |
2003-04-17 |
Wyeth |
Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole
|
|
US7361671B2
(en)
|
2001-11-15 |
2008-04-22 |
The Institute For Pharmaceutical Discovery, Inc. |
Substituted heteroarylalkanoic acids
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
WO2003091258A1
(en)
|
2002-04-26 |
2003-11-06 |
Pfizer Products Inc. |
N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
|
|
AU2003237121A1
(en)
|
2002-04-26 |
2003-11-10 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
|
CA2482838A1
(en)
|
2002-05-31 |
2003-12-11 |
Eisai Co., Ltd. |
Pyrazole compounds and pharmaceutical compositions containing the compound
|
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
|
DK1532145T3
(da)
|
2002-08-02 |
2007-01-15 |
Vertex Pharma |
Pyrazolpræparater der er anvendelige som inhibitorer af GSK-3
|
|
AU2002368154A1
(en)
|
2002-08-08 |
2004-02-25 |
Ribapharm Inc. |
Improved synthesis for hydroxyalkylated heterocyclic bases
|
|
SE0202463D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel compounds
|
|
AU2003286711A1
(en)
|
2002-10-25 |
2004-05-13 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
BR0318145A
(pt)
|
2003-02-26 |
2006-02-21 |
Boehringer Ingelheim Pharma |
dihidropteridinonas, processos para a sua preparação e sua aplicação como medicamento
|
|
JP4787150B2
(ja)
|
2003-03-06 |
2011-10-05 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
Ｊｎｋ阻害剤
|
|
CA2518318A1
(en)
|
2003-03-17 |
2004-09-30 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
GB0308466D0
(en)
|
2003-04-11 |
2003-05-21 |
Novartis Ag |
Organic compounds
|
|
WO2005000813A1
(en)
|
2003-05-30 |
2005-01-06 |
Imclone Systems Incorporated |
Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors
|
|
WO2004106298A1
(en)
|
2003-05-30 |
2004-12-09 |
Janssen Pharmaceutica N.V. |
Indole derivatives with an improved antipsychotic activity
|
|
EP1781659B1
(en)
|
2003-07-16 |
2008-11-05 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
|
EP1675830A4
(en)
|
2003-09-30 |
2008-08-20 |
Scios Inc |
HETEROCYCLIC AMIDES AND SULFONAMIDES
|
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
|
CA2550361C
(en)
|
2003-12-19 |
2014-04-29 |
Prabha Ibrahim |
Compounds and methods for development of ret modulators
|
|
US20070066641A1
(en)
|
2003-12-19 |
2007-03-22 |
Prabha Ibrahim |
Compounds and methods for development of RET modulators
|
|
GB0405055D0
(en)
|
2004-03-05 |
2004-04-07 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
|
TWI372624B
(en)
|
2004-03-30 |
2012-09-21 |
Vertex Pharma |
Azaindoles useful as inhibitors of jak and other protein kinases
|
|
FR2868422B1
(fr)
*
|
2004-03-31 |
2006-07-14 |
Aventis Pharma Sa |
Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
KR20070002081A
(ko)
|
2004-04-02 |
2007-01-04 |
버텍스 파마슈티칼스 인코포레이티드 |
Ｒｏｃｋ 및 기타 단백질 키나아제의 억제제로서 유용한아자인돌
|
|
ITMI20040874A1
(it)
|
2004-04-30 |
2004-07-30 |
Ist Naz Stud Cura Dei Tumori |
Derivati indolici ed azaindolici con azione antitumorale
|
|
KR100476851B1
(ko)
|
2004-05-18 |
2005-03-17 |
(주)성신엔지니어링 |
중력식 섬유여과기
|
|
US20070275954A1
(en)
*
|
2004-05-19 |
2007-11-29 |
Astrazeneca Ab |
Novel Fused Heterocycles and Uses Thereof
|
|
CA2570817A1
(en)
|
2004-06-17 |
2006-01-26 |
Plexxikon, Inc. |
Azaindoles modulating c-kit activity and uses therefor
|
|
DE102004029784A1
(de)
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7173031B2
(en)
|
2004-06-28 |
2007-02-06 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
US20060122213A1
(en)
|
2004-06-30 |
2006-06-08 |
Francoise Pierard |
Azaindoles useful as inhibitors of protein kinases
|
|
EP1781654A1
(en)
|
2004-07-27 |
2007-05-09 |
SGX Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
FR2876103B1
(fr)
*
|
2004-10-01 |
2008-02-22 |
Aventis Pharma Sa |
Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
AU2005294575B2
(en)
|
2004-10-04 |
2011-11-24 |
Millennium Pharmaceuticals, Inc. |
Lactam compounds useful as protein kinase inhibitors
|
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
|
US7855205B2
(en)
|
2004-10-29 |
2010-12-21 |
Janssen Pharmaceutica Nv |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
|
ATE482213T1
(de)
|
2004-11-04 |
2010-10-15 |
Vertex Pharma |
Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
|
|
EP1814883A1
(en)
|
2004-11-22 |
2007-08-08 |
Vertex Pharmaceuticals Incorporated |
Bicyclic inhibitors or rho kinase
|
|
DK2377557T3
(en)
|
2004-11-24 |
2017-02-06 |
Meda Pharmaceuticals Inc |
Compositions comprising azelastine and methods for its use
|
|
EP1828180A4
(en)
|
2004-12-08 |
2010-09-15 |
Glaxosmithkline Llc |
1H-pyrrolo [2,3-BETA] PYRIDINE
|
|
CA2591413A1
(en)
|
2004-12-16 |
2006-06-22 |
Vertex Pharmaceuticals Incorporated |
Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases
|
|
US20060161001A1
(en)
|
2004-12-20 |
2006-07-20 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
CA2596830A1
(en)
|
2005-02-03 |
2006-09-14 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrimidines useful as inhibitors of protein kinase
|
|
DE602006014540D1
(en)
|
2005-05-16 |
2010-07-08 |
Irm Llc |
Pyrrolopyridinderivate als proteinkinaseinhibitoren
|
|
WO2006127587A1
(en)
|
2005-05-20 |
2006-11-30 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
CN102206216B
(zh)
|
2005-06-22 |
2014-11-12 |
普莱希科公司 |
作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物
|
|
EP1749523A1
(en)
|
2005-07-29 |
2007-02-07 |
Neuropharma, S.A. |
GSK-3 inhibitors
|
|
GB0516156D0
(en)
|
2005-08-05 |
2005-09-14 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
|
ZA200802685B
(en)
|
2005-09-30 |
2009-10-28 |
Vertex Pharma |
Deazapurines useful as inhibitors of janus kinases
|
|
US8017781B2
(en)
|
2005-11-15 |
2011-09-13 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
|
US20130096302A1
(en)
|
2005-11-22 |
2013-04-18 |
Hayley Binch |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
|
CN102532133A
(zh)
|
2006-01-17 |
2012-07-04 |
沃泰克斯药物股份有限公司 |
适用作詹纳斯激酶抑制剂的吖吲哚类
|
|
US7659283B2
(en)
|
2006-02-14 |
2010-02-09 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases
|
|
TW200804389A
(en)
|
2006-02-14 |
2008-01-16 |
Vertex Pharma |
Dihydrodiazepines useful as inhibitors of protein kinases
|
|
DE102006012617A1
(de)
|
2006-03-20 |
2007-09-27 |
Merck Patent Gmbh |
4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
|
RS53981B1
(sr)
*
|
2006-03-24 |
2015-10-30 |
Array Biopharma Inc. |
Analozi 2-aminopiridina kao aktivatori glukokinaze
|
|
JP2009532475A
(ja)
|
2006-04-05 |
2009-09-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ヤヌスキナーゼの阻害剤として有用なデアザプリン
|
|
TWI498332B
(zh)
|
2006-04-26 |
2015-09-01 |
Hoffmann La Roche |
作為pi3k抑制劑之嘧啶衍生物及相關製備方法、醫藥組合物、用途、套組及產物
|
|
RU2008141356A
(ru)
|
2006-04-26 |
2010-06-10 |
Ф. Хоффманн-Ля Рош Аг (Ch) |
Производные пиримидина в качестве ингибиторов фосфатидилинозитол-3-киназы (pi3k)
|
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
|
US20090017444A1
(en)
|
2006-06-09 |
2009-01-15 |
Wisconsin Alumni Research Foundation |
Screening method for modulators of viral transcription or replication
|
|
US8778977B2
(en)
|
2006-06-30 |
2014-07-15 |
Sunesis Pharmaceuticals, Inc. |
Pyridinonyl PDK1 inhibitors
|
|
US20080090834A1
(en)
*
|
2006-07-06 |
2008-04-17 |
Pfizer Inc |
Selective azole pde10a inhibitor compounds
|
|
TW200808325A
(en)
|
2006-07-06 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds
|
|
DK2050749T3
(en)
|
2006-08-08 |
2018-01-08 |
Chugai Pharmaceutical Co Ltd |
PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF
|
|
MX2009002046A
(es)
|
2006-08-24 |
2009-03-06 |
Astrazeneca Ab |
Derivados de morfolino pirimidina utiles en el tratamiento de trastornos proliferativos.
|
|
US20130310418A1
(en)
|
2006-11-15 |
2013-11-21 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
|
MX2009006345A
(es)
|
2006-12-14 |
2009-06-23 |
Vertex Pharma |
Compuestos utiles como inhibidores de proteina cinasa.
|
|
AU2007338754A1
(en)
|
2006-12-21 |
2008-07-03 |
Vertex Pharmaceuticals Incorporated |
5-cyan0-4- (pyrrolo [2, 3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
|
TW200840581A
(en)
|
2007-02-28 |
2008-10-16 |
Astrazeneca Ab |
Novel pyrimidine derivatives
|
|
MX2009009590A
(es)
|
2007-03-09 |
2009-11-10 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de proteinas cinasas.
|
|
MX2009009592A
(es)
|
2007-03-09 |
2009-11-10 |
Vertex Pharma |
Aminopiridinas utiles como inhibidores de proteinas cinasas.
|
|
ATE526328T1
(de)
|
2007-03-09 |
2011-10-15 |
Vertex Pharma |
Als inhibitoren von proteinkinasen geeignete aminopyrimidine
|
|
WO2008113711A1
(en)
|
2007-03-22 |
2008-09-25 |
F. Hoffmann-La Roche Ag |
Substituted pyrimidodiazepines useful as plk1 inhibitors
|
|
UA100120C2
(en)
*
|
2007-04-03 |
2012-11-26 |
Анадис Фармасьютикалз, Инк. |
5,6-dihydro-1h-pyridin-2-one compounds
|
|
RU2339637C1
(ru)
|
2007-04-05 |
2008-11-27 |
Андрей Александрович Иващенко |
Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием
|
|
AU2008236872B2
(en)
|
2007-04-05 |
2013-01-17 |
Alla Chem, Llc |
Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and use thereof
|
|
CN101790532B
(zh)
|
2007-07-31 |
2013-11-20 |
沃泰克斯药物股份有限公司 |
5-氟-1H-吡唑并[3，4-b]吡啶-3-胺及其衍生物的制备方法
|
|
CA2695753A1
(en)
|
2007-08-15 |
2009-02-19 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as protein kinases inhibitors
|
|
EP2205603B1
(en)
|
2007-09-28 |
2014-01-15 |
Cyclacel Limited |
Pyrimidine derivatives as protein kinase inhibitors
|
|
AU2008309939B2
(en)
|
2007-10-09 |
2013-11-14 |
European Molecular Biology Laboratory (Embl) |
Soluble fragments of influenza virus PB2 protein capable of binding RNA-cap
|
|
CA2704266A1
(en)
|
2007-11-02 |
2009-06-11 |
Vertex Pharmaceuticals Incorporated |
[1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
|
|
EP2463282B1
(en)
|
2007-11-05 |
2013-08-07 |
Novartis AG |
4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
|
|
JP5368485B2
(ja)
|
2008-02-25 |
2013-12-18 |
エフ．ホフマン−ラ ロシュ アーゲー |
ピロロピラジンキナーゼインヒビター
|
|
WO2009145814A2
(en)
|
2008-03-10 |
2009-12-03 |
Vertex Pharmaceuticals Incorporated |
Pyrimidines and pyridines useful as inhibitors of protein kinases
|
|
EP2297200A1
(en)
|
2008-04-09 |
2011-03-23 |
Technion Research & Development Foundation Ltd. |
Anti influenza antibodies and uses thereof
|
|
WO2010008459A1
(en)
|
2008-06-23 |
2010-01-21 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors
|
|
MX2011000026A
(es)
|
2008-06-23 |
2011-02-24 |
Vertex Pharma |
Inhibidores de proteina cinasas.
|
|
US8569337B2
(en)
|
2008-07-23 |
2013-10-29 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
|
MX2011000834A
(es)
|
2008-07-23 |
2011-04-05 |
Vertex Pharma |
Inhibidores de pirazolopiridin cinasa.
|
|
ES2402087T3
(es)
|
2008-07-23 |
2013-04-26 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de la pirazolopiridina quinasa
|
|
AU2009274023A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
|
US8785489B2
(en)
|
2008-10-17 |
2014-07-22 |
Boehringer Ingelheim International Gmbh |
Heteroaryl substituted indole compounds useful as MMP-13 inhibitors
|
|
CA2760705A1
(en)
|
2009-05-06 |
2010-11-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridines
|
|
US20120093738A1
(en)
|
2009-06-11 |
2012-04-19 |
Rubicon Research Private Limited |
Taste-masked oral formulations of influenza antivirals
|
|
RS57869B1
(sr)
|
2009-06-17 |
2018-12-31 |
Vertex Pharma |
Inhibitori replikacije virusa gripa
|
|
WO2011000566A2
(en)
|
2009-06-30 |
2011-01-06 |
Savira Pharmaceuticals Gmbh |
Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
|
|
CA2767089A1
(en)
|
2009-07-15 |
2011-01-20 |
Abbott Laboratories |
Pyrrolopyridine inhibitors of kinases
|
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
|
MX2012011655A
(es)
|
2010-04-07 |
2012-11-23 |
Vertex Pharma |
Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo [d][1-3]dioxol-5-il]ciclopropanocarboxamido)-3-metilpiridin-2-il) benzoico.
|
|
KR20130094710A
(ko)
|
2010-04-14 |
2013-08-26 |
어레이 바이오파마 인크. |
Ｊａｋ 키나아제의 억제제로서 5,7-치환된-이미다조［1,2-ｃ］피리미딘
|
|
US20130040933A1
(en)
*
|
2010-04-27 |
2013-02-14 |
Brandon Cash |
Azaindoles as janus kinase inhibitors
|
|
MX2013006840A
(es)
|
2010-12-16 |
2014-01-31 |
Vertex Pharma |
Inhibidores de la replicacion de los virus de la influenza.
|
|
CN103492382A
(zh)
|
2010-12-16 |
2014-01-01 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
|
AU2011343642A1
(en)
*
|
2010-12-16 |
2013-05-02 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
CN103702998A
(zh)
|
2011-07-05 |
2014-04-02 |
沃泰克斯药物股份有限公司 |
生产氮杂吲哚类的方法和中间体
|
|
UA118010C2
(uk)
*
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
CA2854879A1
(en)
|
2011-11-07 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
|
|
EP2858984A1
(en)
|
2012-06-08 |
2015-04-15 |
Vertex Pharmaceuticals Inc. |
Inhibitors of influenza viruses replication
|
|
WO2014201332A1
(en)
|
2013-06-14 |
2014-12-18 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical combinations useful for treating rheumatoid arthritis
|
|
EP3036225A1
(en)
|
2013-08-22 |
2016-06-29 |
Vertex Pharmaceuticals Incorporated |
Isotopically enriched azaindoles
|
|
US9296727B2
(en)
|
2013-10-07 |
2016-03-29 |
Vertex Pharmaceuticals Incorporated |
Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
|
|
KR20160084465A
(ko)
|
2013-11-13 |
2016-07-13 |
버텍스 파마슈티칼스 인코포레이티드 |
아자인돌 화합물의 제형
|
|
HRP20181272T1
(hr)
|
2013-11-13 |
2018-10-05 |
Vertex Pharmaceuticals Incorporated |
Postupci priprave inhibitora replikacije virusa influence
|
|
RS59144B1
(sr)
|
2013-11-13 |
2019-09-30 |
Vertex Pharma |
Inhibitori replikacije virusa influence
|
|
MA40773A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus influenza a
|
|
MA40772A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus de la grippe a
|
|
JP6704416B2
(ja)
|
2015-05-13 |
2020-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
|
EP3609502A1
(en)
|
2017-04-12 |
2020-02-19 |
Vertex Pharmaceuticals Incorporated |
Combination therapies for treating influenza virus infection
|